Carisma Therapeutics, Inc. Made Headway

Tue, Jun 10, 2025 at 07:32 PM

Carisma Therapeutics, Inc. (CARM:NASDAQ) rocketted at $1.11, a gain of 389.4%. On Tue, Jun 10, 2025, CARM:NASDAQ touched a New 2-Week High of $1.11. The stock appeared on our News Catalysts scanner on Sat, Jun 07, 2025 at 09:20 PM in the 'MISCELLANEOUS' category. From Tue, May 27, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days

About Carisma Therapeutics, Inc. (CARM:NASDAQ)

Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer.

Top 10 Gainers:

Carisma Therapeutics, Inc. (CARM:NASDAQ), 389.42%
Marin Software Incorporated (MRIN:NASDAQ), 100%
Evogene Ltd. (EVGN:NASDAQ), 100%
NuCana plc (NCNA:NASDAQ), 88.32%
Gelteq Limited (GELS:NASDAQ), 78.79%
Arrive AI Inc. (ARAI:NASDAQ), 62.83%
Magic Empire Global Limited (MEGL:NASDAQ), 60.02%
Ironwood Pharmaceuticals, Inc. (IRWD:NASDAQ), 36.34%
QuantaSing Group Limited (QSG:NASDAQ), 32.95%
Smart for Life, Inc. (SMFL:NASDAQ), 32.31%